GXH: Revenue up 2%, profit down 20% as inflation and lower COVID-19 activity hit margins

About this update from Green Cross Health Ltd

Revenue grew 2% to $503.9m, but EBIT fell 7% and net profit dropped 20% due to inflation and lower COVID-19 activity. Pharmacy and medical segments saw modest revenue growth but margin pressure, with significant investment in new centres and technology. Cash and net assets declined after large dividend payments.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Green Cross Health Ltd